Many aspects of care for fetuses and neonates with congenital heart disease (CHD) fall outside standard practice guidelines, leading to the potential for significant variation in clinical care for this vulnerable population.
We conducted a cross-sectional survey of site sponsors of the Children’s Hospitals Neonatal Consortium, a multicenter collaborative of 41 Level IV neonatal intensive care units to assess key areas of clinical practice variability for patients with fetal and neonatal CHD.
We received responses from 31 centers. Fetal consult services are shared by neonatology and pediatric cardiology at 70% of centers. Three centers (10%) routinely perform fetal magnetic resonance imaging (MRI) for women with pregnancies complicated by fetal CHD. Genetic testing for CHD patients is routine at 76% of centers. Preoperative brain MRI is standard practice at 5 centers (17%), while cerebral NIRS monitoring is regularly used at 14 centers (48%). Use of electroencephalogram (EEG) after major cardiac surgery is routine in 5 centers (17%). Neurodevelopmental follow-up programs are offered at 30 centers (97%).
Many aspects of fetal and neonatal CHD care are highly variable with evolving shared multidisciplinary models.
Many aspects of fetal and neonatal CHD care are highly variable.
Genetic testing, placental examination, preoperative neuroimaging, and postoperative EEG monitoring carry a high yield of finding abnormalities in patients with CHD and these tests may contribute to more precise prognostication and improve care.
Evidence-based standards for prenatal and postnatal CHD care may decrease inter-center variability.
This is a preview of subscription content, access via your institution
Subscribe to Journal
Get full journal access for 1 year
only $9.15 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Get time limited or full article access on ReadCube.
All prices are NET prices.
All data generated or analyzed during this study are included in this published article and its Supplementary Information file.
Hoffman, J. I. & Kaplan, S. The incidence of congenital heart disease. J. Am. Coll. Cardiol. 39, 1890–1900 (2002).
van der Linde, D. et al. Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis. J. Am. Coll. Cardiol. 58, 2241–2247 (2011).
International Society of Ultrasound in Obstetrics & Gynecology. Cardiac screening examination of the fetus: guidelines for performing the ‘basic’ and ‘extended basic’ cardiac scan. Ultrasound Obstet. Gynecol. 27, 107–113 (2006).
Lee, W. et al. ISUOG consensus statement: what constitutes a fetal echocardiogram? Ultrasound Obstet. Gynecol. 32, 239–242 (2008).
Sklansky, M. et al. Maternal psychological impact of fetal echocardiography. J. Am. Soc. Echocardiogr. 15, 159–166 (2002).
Alder, J., Fink, N., Bitzer, J., Hosli, I. & Holzgreve, W. Depression and anxiety during pregnancy: a risk factor for obstetric, fetal and neonatal outcome? A critical review of the literature. J. Matern. Fetal Neonatal Med. 20, 189–209 (2007).
Brosig, C. L., Whitstone, B. N., Frommelt, M. A., Frisbee, S. J. & Leuthner, S. R. Psychological distress in parents of children with severe congenital heart disease: the impact of prenatal versus postnatal diagnosis. J. Perinatol. 27, 687–692 (2007).
Wu, Y. et al. Association of maternal psychological distress with in utero brain development in fetuses with congenital heart disease. JAMA Pediatr. 174, e195316 (2020).
Hamrick, S. E. G. et al. Integrated cardiac care models of neonates with congenital heart disease: the evolving role of the neonatologist. J. Perinatol. 41, 1774–1776 (2021).
Langston, C. et al. Practice guideline for examination of the placenta: developed by the Placental Pathology Practice Guideline Development Task Force of the College of American Pathologists. Arch. Pathol. Lab. Med. 121, 449–476 (1997).
Singh, Y. et al. Recommendations for hemodynamic monitoring for critically ill children-expert consensus statement issued by the Cardiovascular Dynamics Section of the European Society of Paediatric and Neonatal Intensive Care (Espnic). Crit. Care 24, 620 (2020).
Shellhaas, R. A. et al. The American Clinical Neurophysiology Society’s guideline on continuous electroencephalography monitoring in neonates. J. Clin. Neurophysiol. 28, 611–617 (2011).
Marino, B. S. et al. Neurodevelopmental outcomes in children with congenital heart disease: evaluation and management: a Scientific Statement from the American Heart Association. Circulation 126, 1143–1172 (2012).
Harris, P. A. et al. Research Electronic Data capture (REDcap)–a metadata-driven methodology and workflow process for providing translational research informatics support. J. Biomed. Inf. 42, 377–381 (2009).
Harris, P. A. et al. The REDcap Consortium: building an international community of software platform partners. J. Biomed. Inf. 95, 103208 (2019).
Miquel-Verges, F. et al. Prenatal consultation with a neonatologist for congenital anomalies: parental perceptions. Pediatrics 124, e573–e579 (2009).
Leithner, K., Maar, A. & Maritsch, F. Experiences with a psychological help service for women following a prenatal diagnosis: results of a follow-up study. J. Psychosom. Obstet. Gynaecol. 23, 183–192 (2002).
Rychik, J. et al. Maternal psychological stress after prenatal diagnosis of congenital heart disease. J. Pediatr. 162, 302.e1–307.e1 (2013).
Bratt, E. L. et al. Parental reactions, distress, and sense of coherence after prenatal versus postnatal diagnosis of complex congenital heart disease. Cardiol. Young 29, 1328–1334 (2019).
Maina, G. et al. Impact of maternal psychological distress on fetal weight, prematurity and intrauterine growth retardation. J. Affect. Disord. 111, 214–220 (2008).
Fenster, L. et al. Psychologic stress in the workplace and spontaneous abortion. Am. J. Epidemiol. 142, 1176–1183 (1995).
Kurki, T., Hiilesmaa, V., Raitasalo, R., Mattila, H. & Ylikorkala, O. Depression and anxiety in early pregnancy and risk for preeclampsia. Obstet. Gynecol. 95, 487–490 (2000).
Van den Bergh, B. R., Mulder, E. J., Mennes, M. & Glover, V. Antenatal maternal anxiety and stress and the neurobehavioural development of the fetus and child: links and possible mechanisms. a review. Neurosci. Biobehav. Rev. 29, 237–258 (2005).
Harris, K. W., Brelsford, K. M., Kavanaugh-McHugh, A. & Clayton, E. W. Uncertainty of prenatally diagnosed congenital heart disease: a qualitative study. JAMA Netw. Open 3, e204082 (2020).
Bratt, E. L., Jarvholm, S., Ekman-Joelsson, B. M., Mattson, L. A. & Mellander, M. parent’s experiences of counselling and their need for support following a prenatal diagnosis of congenital heart disease–a qualitative study in a Swedish context. BMC Pregnancy Childbirth 15, 171 (2015).
Marc-Aurele, K. L. Decisions parents make when faced with potentially life-limiting fetal diagnoses and the importance of perinatal palliative care. Front. Pediatr. 8, 574556 (2020).
Afonso, N. S. et al. Redefining the relationship: palliative care in critical perinatal and neonatal cardiac patients. Children 8, 548 (2021).
Committee Opinion No. 723. Guidelines for diagnostic imaging during pregnancy and lactation. Obstet. Gynecol. 130, e210–e216 (2017).
Committee on Practice Parameters - Pediatric Radiology of the ACR Commission on Pediatric Radiology. ACR-SPR practice parameter for the safe and optimal performance of fetal magnetic resonance imaging (MRI). https://www.acr.org/-/media/ACR/Files/Practice-Parameters/mr-fetal.pdf (2020).
Herrmann, J. L. et al. Congenital pulmonary lymphangiectasia and early mortality after stage 1 reconstruction procedures. Cardiol. Young 27, 1356–1360 (2017).
Peyvandi, S. et al. Timing and mode of delivery in prenatally diagnosed congenital heart disease- an analysis of practices within the University of California Fetal Consortium (UCFC). Pediatr. Cardiol. 38, 588–595 (2017).
Castellanos, D. A. et al. Trends in preterm delivery among singleton gestations with critical congenital heart disease. J. Pediatr. 222, 28–34.e4 (2020).
Kipps, A. K. et al. Prenatal diagnosis of hypoplastic left heart syndrome in current era. Am. J. Cardiol. 108, 421–427 (2011).
Levey, A. et al. The impact of prenatal diagnosis of complex congenital heart disease on neonatal outcomes. Pediatr. Cardiol. 31, 587–597 (2010).
Ge, C. J. et al. Fetal CHD and perinatal outcomes. Cardiol. Young 30, 686–691 (2020).
Landis, B. J. et al. Prenatal diagnosis of congenital heart disease and birth outcomes. Pediatr. Cardiol. 34, 597–605 (2013).
Costello, J. M. et al. Gestational age at birth and outcomes after neonatal cardiac surgery: an Analysis of the Society of Thoracic Surgeons Congenital Heart Surgery Database. Circulation 129, 2511–2517 (2014).
Afshar, Y. et al. Multi-institutional practice-patterns in fetal congenital heart disease following implementation of a standardized clinical assessment and management plan. J. Am. Heart Assoc. 10, e021598 (2021).
Roescher, A. M., Timmer, A., Erwich, J. J. & Bos, A. F. Placental pathology, perinatal death, neonatal outcome, and neurological development: a systematic review. PLoS ONE 9, e89419 (2014).
Weiner, E. et al. The role of placental histopathological lesions in predicting recurrence of preeclampsia. Prenat. Diagn. 36, 953–960 (2016).
Leon, R. L. et al. Neuroplacentology in congenital heart disease: placental connections to neurodevelopmental outcomes. Pediatr. Res. 91, 787–794 (2022).
Mir, I. N. et al. Impact of multiple placental pathologies on neonatal death, bronchopulmonary dysplasia, and neurodevelopmental impairment in preterm infants. Pediatr. Res. 87, 885–891 (2020).
Mir, I. N. et al. Placental pathology is associated with severity of neonatal encephalopathy and adverse developmental outcomes following hypothermia. Am. J. Obstet. Gynecol. 213, 849.e841–847 (2015).
Benirschke, K. The placenta in the litigation process. Am. J. Obstet. Gynecol. 162, 1445–1448 (1990) ; discussion 1448–1450.
Albalawi, A. et al. Placental characteristics of fetuses with congenital heart disease. J. Ultrasound Med. 36, 965–972 (2017).
Rychik, J. et al. Characterization of the placenta in the newborn with congenital heart disease: distinctions based on type of cardiac malformation. Pediatr. Cardiol. 39, 1165–1171 (2018).
Pierpont, M. E. et al. Genetic basis for congenital heart disease: revisited: a Scientific Statement from the American Heart Association. Circulation 138, e653–e711 (2018).
Boskovski, M. T. et al. De novo damaging variants, clinical phenotypes, and post-operative outcomes in congenital heart disease. Circ. Genom. Precis. Med. 13, e002836 (2020).
Landis, B. J. & Ware, S. M. The current landscape of genetic testing in cardiovascular malformations: opportunities and challenges. Front. Cardiovasc. Med. 3, 22 (2016).
Russell, M. W., Chung, W. K., Kaltman, J. R. & Miller, T. A. Advances in the understanding of the genetic determinants of congenital heart disease and their impact on clinical outcomes. J. Am. Heart Assoc. 7, e006906 (2018).
Miller, S. P. et al. Abnormal brain development in newborns with congenital heart disease. N. Engl. J. Med. 357, 1928–1938 (2007).
Kelly, C. J. et al. Neuroimaging findings in newborns with congenital heart disease prior to surgery: an observational study. Arch. Dis. Child. 104, 1042–1048 (2019).
Glauser, T. A., Rorke, L. B., Weinberg, P. M. & Clancy, R. R. Congenital brain anomalies associated with the hypoplastic left heart syndrome. Pediatrics 85, 984–990 (1990).
Peyvandi, S. et al. Neonatal brain injury and timing of neurodevelopmental assessment in patients with congenital heart disease. J. Am. Coll. Cardiol. 71, 1986–1996 (2018).
Peyvandi, S. et al. Fetal brain growth and risk of postnatal white matter injury in critical congenital heart disease. J. Thorac. Cardiovasc. Surg. 162, 1007.e1–1014.e1 (2021).
Licht, D. J. et al. Brain maturation is delayed in infants with complex congenital heart defects. J. Thorac. Cardiovasc. Surg. 137, 529–536 (2009); discussion 536–527.
Peyvandi, S., Latal, B., Miller, S. P. & McQuillen, P. S. The neonatal brain in critical congenital heart disease: insights and future directions. Neuroimage 185, 776–782 (2019).
Naim, M. Y. et al. Subclinical seizures identified by postoperative electroencephalographic monitoring are common after neonatal cardiac surgery. J. Thorac. Cardiovasc. Surg. 150, 169–178 (2015); discussion 178–180.
We are indebted to the following institutions that serve the infants and their families, and these institutions also have invested in and continue to participate in the Children’s Hospital’s Neonatal Database (CHND). Jeanette Asselin, Beverly Brozanski, David Durand (ex officio), Francine Dykes (ex officio), Jacquelyn Evans (Executive Director), Theresa Grover, Karna Murthy (Chair), Michael Padula, Eugenia Pallotto, Anthony Piazza, Kristina Reber, and Billie Short are members of the Children’s Hospitals Neonatal Consortium, Inc. For more information, please contact: email@example.com.
No funding was obtained for this study. The Children’s Hospitals Neonatal Consortium provided administrative support for survey distribution.
The authors declare no competing interests.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Leon, R.L., Levy, P.T., Hu, J. et al. Practice variations for fetal and neonatal congenital heart disease within the Children’s Hospitals Neonatal Consortium. Pediatr Res (2022). https://doi.org/10.1038/s41390-022-02314-2